SynAct Pharma Draws SEK50 Million from New Financing Facility

MT Newswires · 3d ago
06:11 AM EDT, 07/20/2026 (MT Newswires) -- SynAct Pharma (SYNACT.ST) secured a 100 million-krona financing facility and has drawn 50 million kronor through a convertible loan issue. The clinical-stage biotechnology company said Monday it will use the funding to bolster its financial position and advance its preparations for phase 3 development. It added that the balance will be utilized if and when it is strategically beneficial for the company.